- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/06 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 401/06
Total number of patents in this class: 4830
10-year publication summary
|
311
|
345
|
401
|
344
|
307
|
280
|
311
|
241
|
267
|
186
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2700 |
96 |
| Janssen Pharmaceutica N.V. | 3142 |
92 |
| Merck Sharp & Dohme LLC | 3734 |
79 |
| Bristol-myers Squibb Company | 4761 |
67 |
| Boehringer Ingelheim International GmbH | 4480 |
67 |
| F. Hoffmann-La Roche AG | 7792 |
66 |
| Novartis AG | 10172 |
63 |
| VALO Health, Inc. | 195 |
53 |
| Syngenta Crop Protection AG | 6789 |
41 |
| The Regents of the University of California | 20924 |
37 |
| Merck Patent GmbH | 5755 |
37 |
| Centre National de La Recherche Scientifique | 11122 |
35 |
| Eli Lilly and Company | 4135 |
35 |
| Allergan, Inc. | 2146 |
33 |
| Toray Industries, Inc. | 7163 |
32 |
| Mycovia Pharmaceuticals, Inc. | 40 |
32 |
| Hoffmann-La Roche Inc. | 3849 |
31 |
| ChemoCentryx, Inc. | 361 |
30 |
| BASF SE | 21318 |
26 |
| Astellas Pharma Inc. | 1039 |
26 |
| Other owners | 3852 |